» Articles » PMID: 28621039

WblA, a Pleiotropic Regulatory Gene Modulating Morphogenesis and Daptomycin Production in Streptomyces Roseosporus

Overview
Date 2017 Jun 17
PMID 28621039
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The wblA gene, encoding a homologue of the WhiB family protein, was identified in the sequenced genome of daptomycin producer Streptomyces roseosporus. To explore the function of wblA, we construct wblA disruption strains, complemented strains and overexpression strains to test whether it can affect the production of secondary metabolites and morphogenesis.

Methods And Results: We constructed disruption strains by homologous recombination in S. roseosporus. The disruption mutant of wblA could block aerial mycelium sporulation and enhance the production of daptomycin by 51%. In contrast, overexpression of wblA resulted in significantly decreased the yield of daptomycin. In agreement with it, the transcription of key daptomycin regulatory genes atrA, dptR2 and dptR3 and structural gene dptE remarkably increased in the wblA disruption mutant.

Conclusions: wblA plays a key role in control of daptomycin biosynthesis and is essential for sporulation. The disruption of wblA could accumulate the transcription level of some key genes involving in daptomycin biosynthesis.

Significance And Impact Of The Study: Daptomycin is an important antibiotic with potent activity against a variety of Gram-positive pathogens. This study demonstrates that valuable improvement in the yield of daptomycin can be achieved through modulating the expression of wblA transcription regulator.

Citing Articles

The Transcriptional Regulator DhyR Positively Modulates Daptomycin Biosynthesis in Streptomyces roseosporus.

He F, Liu X, Wang H, Li X, Wu Y, Zhang D Microb Biotechnol. 2025; 18(3):e70110.

PMID: 40025688 PMC: 11872808. DOI: 10.1111/1751-7915.70110.


A rational multi-target combination strategy for synergistic improvement of non-ribosomal peptide production.

Yan H, Xin Z, Sang Z, Li X, Xie J, Wu J Nat Commun. 2025; 16(1):1883.

PMID: 39987186 PMC: 11847002. DOI: 10.1038/s41467-025-57073-5.


Metabolic engineering of to enhance the synthesis of valuable natural products.

Xu Z, Ji L, Tang W, Guo L, Gao C, Chen X Eng Microbiol. 2024; 2(2):100022.

PMID: 39628845 PMC: 11611008. DOI: 10.1016/j.engmic.2022.100022.


Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin.

Li X, Sang Z, Zhao X, Wen Y Microb Biotechnol. 2024; 17(11):e70038.

PMID: 39487765 PMC: 11530997. DOI: 10.1111/1751-7915.70038.


Manipulation and epigenetic control of silent biosynthetic pathways in actinobacteria.

Karimian S, Farahmandzad N, Mohammadipanah F World J Microbiol Biotechnol. 2024; 40(2):65.

PMID: 38191749 DOI: 10.1007/s11274-023-03861-4.